首页 > 最新文献

Journal of Molecular Medicine最新文献

英文 中文
Abnormal protein SUMOylation in liver disease: novel target for therapy 肝病中的异常蛋白 SUMOylation:新的治疗靶点
Pub Date : 2024-04-03 DOI: 10.1007/s00109-024-02440-w
Yanfang Yang, Fuxun Yu

SUMOylation is an important protein post-translational modification (PTM) process, in which the small ubiquitin-like modifier (SUMO) protein covalently binds to the target protein and regulates stability, subcellular localization, and protein–protein interaction of the target protein. Protein SUMOylation exerts crucial regulatory function in the liver, and its abnormalities are associated with various liver-related disease processes. This review focuses on the biological functions of protein SUMOylation in liver-related diseases in recent years, summarizes the molecular mechanisms of SUMOylation in the replication of hepatitis viruses and the occurrence of hepatocellular carcinoma, and discusses the significance of SUMOylation in liver-related disorders, which is essential for understanding liver biological processes and formulating therapeutic strategies.

SUMO酰化是一种重要的蛋白质翻译后修饰(PTM)过程,在这一过程中,小泛素样修饰蛋白(SUMO)与目标蛋白共价结合,并调节目标蛋白的稳定性、亚细胞定位以及蛋白与蛋白之间的相互作用。蛋白质 SUMOylation 在肝脏中发挥着重要的调节功能,其异常与各种肝脏相关疾病过程有关。本综述重点探讨了近年来蛋白质 SUMOylation 在肝脏相关疾病中的生物学功能,总结了 SUMOylation 在肝炎病毒复制和肝细胞癌发生中的分子机制,并讨论了 SUMOylation 在肝脏相关疾病中的意义,这对于理解肝脏生物学过程和制定治疗策略至关重要。
{"title":"Abnormal protein SUMOylation in liver disease: novel target for therapy","authors":"Yanfang Yang, Fuxun Yu","doi":"10.1007/s00109-024-02440-w","DOIUrl":"https://doi.org/10.1007/s00109-024-02440-w","url":null,"abstract":"<p>SUMOylation is an important protein post-translational modification (PTM) process, in which the small ubiquitin-like modifier (SUMO) protein covalently binds to the target protein and regulates stability, subcellular localization, and protein–protein interaction of the target protein. Protein SUMOylation exerts crucial regulatory function in the liver, and its abnormalities are associated with various liver-related disease processes. This review focuses on the biological functions of protein SUMOylation in liver-related diseases in recent years, summarizes the molecular mechanisms of SUMOylation in the replication of hepatitis viruses and the occurrence of hepatocellular carcinoma, and discusses the significance of SUMOylation in liver-related disorders, which is essential for understanding liver biological processes and formulating therapeutic strategies.</p>","PeriodicalId":16341,"journal":{"name":"Journal of Molecular Medicine","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140575156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging therapeutic targets in systemic sclerosis 系统性硬化症的新治疗靶点
Pub Date : 2024-02-22 DOI: 10.1007/s00109-024-02424-w

Abstract

Systemic sclerosis is an autoimmune connective tissue disease which is characterised by vascular perturbations, inflammation, and fibrosis. Although huge progress recently into the underlying molecular pathways that are perturbed in the disease, currently no therapy exists that targets the fibrosis element of the disease and consequently there is a huge unmet medical need. Emerging studies reveal new dimensions of complexity, and multiple aberrant pathways have been uncovered that have shed light on disturbed signalling in the disease, primarily in inflammatory pathways that can be targeted with repurposed drugs. Pre-clinical animal models using these inhibitors have yielded proof of concept for targeting these signalling systems and progressing to clinical trials. This review will examine the recent evidence of new perturbed pathways in SSc and how these can be targeted with new or repurposed drugs to target a currently intractable disease.

摘要 系统性硬化症是一种自身免疫性结缔组织疾病,其特点是血管紊乱、炎症和纤维化。尽管最近在研究该病的潜在分子通路方面取得了巨大进展,但目前还没有针对该病纤维化因素的疗法,因此存在着巨大的未满足医疗需求。新的研究揭示了复杂性的新层面,发现了多种异常途径,揭示了疾病中紊乱的信号传导,主要是炎症途径,这些途径可以用重新设计的药物进行靶向治疗。使用这些抑制剂的临床前动物模型已经证明了靶向这些信号系统的概念,并已进入临床试验阶段。本综述将探讨最近有关 SSc 中新的紊乱通路的证据,以及如何利用新药或重新设计的药物来靶向治疗这种目前难以治愈的疾病。
{"title":"Emerging therapeutic targets in systemic sclerosis","authors":"","doi":"10.1007/s00109-024-02424-w","DOIUrl":"https://doi.org/10.1007/s00109-024-02424-w","url":null,"abstract":"<h3>Abstract</h3> <p>Systemic sclerosis is an autoimmune connective tissue disease which is characterised by vascular perturbations, inflammation, and fibrosis. Although huge progress recently into the underlying molecular pathways that are perturbed in the disease, currently no therapy exists that targets the fibrosis element of the disease and consequently there is a huge unmet medical need. Emerging studies reveal new dimensions of complexity, and multiple aberrant pathways have been uncovered that have shed light on disturbed signalling in the disease, primarily in inflammatory pathways that can be targeted with repurposed drugs. Pre-clinical animal models using these inhibitors have yielded proof of concept for targeting these signalling systems and progressing to clinical trials. This review will examine the recent evidence of new perturbed pathways in SSc and how these can be targeted with new or repurposed drugs to target a currently intractable disease.</p>","PeriodicalId":16341,"journal":{"name":"Journal of Molecular Medicine","volume":"184 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139928032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Etiopathogenesis of medication-related osteonecrosis of the jaws: a review 药物性颌骨坏死的发病机制:综述
Pub Date : 2024-02-02 DOI: 10.1007/s00109-024-02425-9

Abstract

This study compiles the main hypotheses involved in the etiopathogenesis of medication-related osteonecrosis of the jaw (MRONJ). A narrative review of the literature was performed. The etiopathogenesis of MRONJ is multifactorial and not fully understood. The main hypothesis considers the disturbance of bone turnover caused by anti-resorptive drugs. Bisphosphonates and denosumab inhibit osteoclast activity through different action mechanisms, accumulating bone microfracture. Other hypotheses also consider oral infection and inflammation, the antiangiogenic effect and soft tissue toxicity of bisphosphonates, and the inhibition of lymphangiogenesis. Knowledge of the current theories for MRONJ is necessary to define future studies and protocols to minimize the incidence of this severe condition.

摘要 本研究汇编了药物相关性颌骨坏死(MRONJ)病因发病机制的主要假说。对文献进行了叙述性回顾。MRONJ的发病机制是多因素的,尚未完全明了。主要的假说是抗骨质吸收药物引起的骨转换紊乱。双膦酸盐和地诺单抗通过不同的作用机制抑制破骨细胞的活性,从而累积骨微骨折。其他假说还考虑了口腔感染和炎症、双膦酸盐的抗血管生成作用和软组织毒性以及对淋巴管生成的抑制。了解目前有关 MRONJ 的理论对于确定未来的研究和治疗方案很有必要,以便将这种严重病症的发病率降至最低。
{"title":"Etiopathogenesis of medication-related osteonecrosis of the jaws: a review","authors":"","doi":"10.1007/s00109-024-02425-9","DOIUrl":"https://doi.org/10.1007/s00109-024-02425-9","url":null,"abstract":"<h3>Abstract</h3> <p>This study compiles the main hypotheses involved in the etiopathogenesis of medication-related osteonecrosis of the jaw (MRONJ). A narrative review of the literature was performed. The etiopathogenesis of MRONJ is multifactorial and not fully understood. The main hypothesis considers the disturbance of bone turnover caused by anti-resorptive drugs. Bisphosphonates and denosumab inhibit osteoclast activity through different action mechanisms, accumulating bone microfracture. Other hypotheses also consider oral infection and inflammation, the antiangiogenic effect and soft tissue toxicity of bisphosphonates, and the inhibition of lymphangiogenesis. Knowledge of the current theories for MRONJ is necessary to define future studies and protocols to minimize the incidence of this severe condition.</p>","PeriodicalId":16341,"journal":{"name":"Journal of Molecular Medicine","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139664194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liquid–liquid phase separation in Alzheimer’s disease 阿尔茨海默病中的液-液相分离技术
Pub Date : 2024-01-02 DOI: 10.1007/s00109-023-02407-3
Qinggang Fu, Bixiang Zhang, Xiaoping Chen, Liang Chu

The pathological aggregation and misfolding of tau and amyloid-β play a key role in Alzheimer’s disease (AD). However, the underlying pathological mechanisms remain unclear. Emerging evidences indicate that liquid–liquid phase separation (LLPS) has great impacts on regulating human health and diseases, especially neurodegenerative diseases. A series of studies have revealed the significance of LLPS in AD. In this review, we summarize the latest progress of LLPS in AD, focusing on the impact of metal ions, small-molecule inhibitors, and proteinaceous partners on tau LLPS and aggregation, as well as toxic oligomerization, the role of LLPS on amyloid-β (Aβ) aggregation, and the cross-interactions between amyloidogenic proteins in AD. Eventually, the fundamental methods and techniques used in LLPS study are introduced. We expect to present readers a deeper understanding of the relationship between LLPS and AD.

tau 和淀粉样蛋白-β的病理聚集和错误折叠在阿尔茨海默病(AD)中起着关键作用。然而,其潜在的病理机制仍不清楚。新的证据表明,液-液相分离(LLPS)对调节人类健康和疾病,尤其是神经退行性疾病有重大影响。一系列研究已经揭示了液相-液相分离在多发性硬化症中的重要作用。在这篇综述中,我们总结了LLPS在AD中的最新研究进展,重点介绍了金属离子、小分子抑制剂和蛋白伴侣对tau LLPS和聚集以及毒性寡聚的影响,LLPS对淀粉样蛋白-β(Aβ)聚集的作用,以及AD中淀粉样蛋白之间的交叉相互作用。最后,介绍了 LLPS 研究中使用的基本方法和技术。我们期待读者能更深入地了解 LLPS 与 AD 之间的关系。
{"title":"Liquid–liquid phase separation in Alzheimer’s disease","authors":"Qinggang Fu, Bixiang Zhang, Xiaoping Chen, Liang Chu","doi":"10.1007/s00109-023-02407-3","DOIUrl":"https://doi.org/10.1007/s00109-023-02407-3","url":null,"abstract":"<p>The pathological aggregation and misfolding of tau and amyloid-β play a key role in Alzheimer’s disease (AD). However, the underlying pathological mechanisms remain unclear. Emerging evidences indicate that liquid–liquid phase separation (LLPS) has great impacts on regulating human health and diseases, especially neurodegenerative diseases. A series of studies have revealed the significance of LLPS in AD. In this review, we summarize the latest progress of LLPS in AD, focusing on the impact of metal ions, small-molecule inhibitors, and proteinaceous partners on tau LLPS and aggregation, as well as toxic oligomerization, the role of LLPS on amyloid-β (Aβ) aggregation, and the cross-interactions between amyloidogenic proteins in AD. Eventually, the fundamental methods and techniques used in LLPS study are introduced. We expect to present readers a deeper understanding of the relationship between LLPS and AD.</p>","PeriodicalId":16341,"journal":{"name":"Journal of Molecular Medicine","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139079112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estrogen receptors in normal human myometrium and leiomyoma. 正常人子宫肌层和平滑肌瘤中的雌激素受体。
Pub Date : 1977-01-01
K Pollow, M Schmidt-gollwitzer, E Boquoi, B Pollow
{"title":"Estrogen receptors in normal human myometrium and leiomyoma.","authors":"K Pollow,&nbsp;M Schmidt-gollwitzer,&nbsp;E Boquoi,&nbsp;B Pollow","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":16341,"journal":{"name":"Journal of Molecular Medicine","volume":"2 1","pages":"61-8"},"PeriodicalIF":0.0,"publicationDate":"1977-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22023437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Molecular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1